Duchenne Research Fund
  • Home
  • Duchenne facts
  • Our story
  • Our projects
  • News
  • Get involved
    • Get involved
    • Gallery
  • Contact
  • Donate
Select Page

Vamorolone shows improvements in strength and endurance in boys with Duchenne

26 Jun 2018

We are pleased to share an update from ReveraGen about its Vamorolone clinical trial. Vamorolone is an alternative treatment to existing steroids that aims to maximise the benefits while reducing the side effects. In 2014, The Duchenne Research Fund helped fund the...

Most recent:

  • Duchenne Care UK podcast series launched
  • Duchenne Care UK orthopaedic guideline recognised by NICE
  • Landmark day for Duchenne as Givinostat approved for use in England
  • Solid doses first patient on Phase 3 trial
  • Duchenne Care UK launches psychosocial guidelines

More about our projects:

administrative post award clinical post complementary current drug development early stage facility gene therapy past post project research standards of care

Jump to:

  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Facebook
  • Twitter
  • Instagram
Copyright © 2026 The Duchenne Research Fund. Registered Charity No. 1119068. Website by Sheli Rodney